2nd German Cancer Research Congress (GCRC) | 2. Deutscher Krebsforschungskongress (DKFK)
Communication Center of the DKFZ
© Jutta Jung/DKFZ
After the first successful edition of the German Cancer Research Congress in early 2019, the 2. German Cancer Research Congress will take place on 18 and 19 October 2021 as a virtual conference.
Again, the German Cancer Society, German Cancer Aid and the DKFZ will organise the congress together with their networks, the CCC Network, the German Cancer Consortium (DKTK), the National Centres for Tumour Diseases (NCT) and the AEK to present the performance of oncological research in Germany.
There will be 4 Sessions on the new developments in Cancer Prevention, Basic Cancer Research, Preclinical Cancer Research and Early Clinical Cancer Research. In addition, serveral Workshops and a Poster Exhibition will provide insights into the exciting field of cancer research.
Although the Corona pandemic has made it more difficult to plan events, we will make every effort to once again offer an attractive platform for cancer researchers to present excellent cancer research, network and interact at the 2nd German Cancer Research Congress.
We would be delighted to welcome you to the 2. German Cancer Research Congress.
The Congress Presidents
Michael Baumann, German Cancer Research Center, Heidelberg
Gerd Nettekoven, German Cancer Aid, Bonn
Thomas Seufferlein, German Cancer Society, Berlin
The following speakers for our four plenary sessions are already confirmed:
- Bertram Bengsch, Freiburg
- Uta Höpken, Berlin
- Lena Illert, Freiburg
- Fabian Kiessling, Aachen
- Christiane Opitz, Heidelberg
- Roland Rad, Munich
- Claudia Rössig, Münster
- Lisa Sevenich, Frankfurt
- Robert Zeiser, Freiburg
- Phillipp Zimmer, Dortmund
- The two prize winners of the „German Prize for Cancer Prevention Research" – a prize sponsored by the Manfred Lautenschläger Foundation gGmbH
In addition, we offer 12 interactive workshops on various topics across the entire spectrum of cancer research:
- Molecular Prevention: From Preclinical Models to Translation
- New Chemical Biology
- Molecular Tumor Board
- Digital Pathology and AI
- Theranostics and Tumor-Targeted Drug Delivery
- Aging & Cancer - Towards Understanding The Major Risk Factor For Cancer
- Patient-oriented Research on Cancer-associated Fatigue
- Interpretation of Sequencing Data for Personalized Medicine
- Centers for Personalized Medicine (ZPM) - An Innovative Research Structure
- Data Driven Medicine
- Cancer Immunotherapy
- Epigenetic Medicine in Cancer
The third highlight will be a large virtual poster exhibition, where the top poster authors will have the opportunity to present their work in a session. Take advantage of this opportunity and submit your abstract for the poster exhibition now! Abstract submission is closed!
Registration Fees:
Regular: 75 €
Student: 50 €
[Note for DKFZ employees: The registration fee will be charged internally, however completing the registration process is still mandatory].
Registration and further information
The congress is certified by the medical association ("Landesärztekammer") of Baden-Württemberg" as follows:
18th October: 4 CME credits cat. A
19th October: 3 CME credits cat. A
About two weeks after the Conference you will receive a certificate of attendance via email.
Further questions, please contact: dkfk@kukm.de
Scientific Program Committee
Melanie Börries, German Cancer Consortium, Freiburg
Angelika Eggert, Carité Berlin, Berlin
Martin Eilers, University of Würzburg
Rainer Engers, Center for Pathology, Cytology and Molecular Pathology, Neuss
Christine Falk, Hannover Medical School, Hannover
Florian Greten, Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt
Mathias Heikenwälder, German Cancer Research Center, Heidelberg
Ruth Knüchel-Clarke, University Hospital, Aachen
Karen Steindorf, German Cancer Research Center, Heidelberg
Frederik Wenz, University Hospital, Freiburg
